# Intra-Arterial Tirofiban After Complete Recanalization for Acute Intracranial Large-Vessel Occlusion

> **NCT07537933** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Shandong Provincial Hospital** · enrollment: 344 (estimated)

## Conditions studied

- Acute Ischemic Stroke
- Large-vessel Occlusion
- Endovascular Treatment

## Interventions

- **DRUG:** Tirofiban

## Key facts

- **NCT ID:** NCT07537933
- **Lead sponsor:** Shandong Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2028-04
- **Final completion:** 2028-04
- **Target enrollment:** 344 (ESTIMATED)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07537933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07537933, "Intra-Arterial Tirofiban After Complete Recanalization for Acute Intracranial Large-Vessel Occlusion". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07537933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*